The difference between winning and losing intellectual property strategies are often subtle. Adopted best practices often only establish a place in the contest. Actually winning can take much more. Join the new Head of IP at Mieza Technologies as he seeks to defend Mieza Technology’s horse chip, an artificial intelligence device that allows automobiles to override driver commands that would otherwise cause accidents. Through a series of IP strategy war games disguised as dreams he learns that patents alone will not win the day and that often the best defense needs a good offense as well. The Defense of the Mieza HChip is the first in a series of IP strategy books written by Think IP Strategy. This book focuses on the protection and exploitation of IP in hi-tech. Additional titles in the series will address life sciences, entertainment, consumer products, and other industries.

The differences between winning and losing intellectual property strategies are often subtle. Adopted best practices often only establish a place in the contest. Actually winning can take much more. Join the new Head of IP at Mieza Therapeutics as he seeks to defend Mieza Therapeutic’s new compound, a combination product that promises revolutionary treatment for Idiopathic Pneumonia. Through a series of IP strategy war games disguised as dreams he learns that patents alone will not win the day and that often the best defense needs a good offense as well. The Defense of the Mieza Compound is the second in a series of IP strategy books written by Think IP Strategy. This book focuses on the protection and exploitation of IP in Life Sciences. The first edition (The Defense of the Mieza HChip) was focused on the Tech industry. Additional titles in the series will address manufacturing, entertainment, consumer products, and other industries.

This book highlights the special issues arising in obtaining, commercialising, enforcing or attacking intellectual property rights (including protection of regulatory data) in the pharmaceutical, biotechnology and chemical industries across the world’s key jurisdictions. It is unique in presenting topic matter horizontally by subject to facilitate comparison between country practices.

The first two chapters give a general introduction to the differences between the jurisdictions and an overview of some of the key concepts in patent law. The remainder of the book is dedicated to a detailed analysis of the major legal issues arising in these areas of technology. Each component chapter has a comparative introduction, looking at the variances in the laws of different domains, followed by side-by-side analysis of the relevant regimes, including tables and flow-charts which summarise and explain the key legal concepts. The jurisdictions covered are the United States, Europe (UK, Germany, Netherlands, France and Italy), Japan, Canada, Australia, India and China.

Readership: Patent agents, patent attorneys, solicitors and barristers working in patent and intellectual property law worldwide. Scientists, researchers and managers in the chemicals, pharmaceuticals and biotechnology industries.